---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42184893.md"
description: "$Regencell Bioscience(RGC.US) has dropped another -23%, with no new fundamental news. The market pressure still stems more from the shadow of that securities class action lawsuit and the earlier regulatory investigation.Can you still trust this kind of stock that has zero revenue, propped up by a TCM (Traditional Chinese Medicine) concept to a sky-high market cap, and is now entangled in lawsuits? My view is that the fundamentals column was always empty to begin with. What's been lost is the emotional premium that was hyped up earlier. It's still far from reasonable valuation, and any rebound is only suitable for trading on sentiment, not as a value investment.😵"
datetime: "2026-06-25T10:00:12.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42184893.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42184893.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42184893.md)
author: "[袋鼠](https://longbridge.com/en/profiles/27248405.md)"
---

# $Regencell Bioscience(RGC.US) has dropped another …


### Related Stocks

- [RGC.US](https://longbridge.com/en/quote/RGC.US.md)

## Comments (1)

- **刘舒心266866 · 2026-06-25T15:54:49.000Z**: Is this the first time such a lawsuit has been triggered?